Industry

GUILFORD, Conn. & NEW YORK–(BUSINESS WIRE)–Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a digital health company transforming care with handheld, whole-body ultrasound, announced that it will report second quarter 2022 financial results and provide a business update on August 3, 2022, before the market opens. Dr. Todd Fruchterman, President and Chief Executive Officer, and Heather Getz, … [Read more…]

PARSIPPANY, N.J.–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq: ISEE) today announced that it will report its second quarter 2022 financial and operating results on Tuesday, July 26, 2022. Following the announcement, the Iveric Bio management team will host a live conference call and webcast at 8:00 a.m. Eastern Time to discuss the Company’s financial results and provide … [Read more…]

Total Enterprise Value of Approximately $1.25 Billion AUSTIN, Texas–(BUSINESS WIRE)–Hanger, Inc. (NYSE: HNGR), a leading provider of orthotic and prosthetic (O&P) patient care services and solutions, announced today that it has entered into a definitive agreement to be acquired by Patient Square Capital, a dedicated health care investment firm. Under the terms of the agreement, … [Read more…]

CHICAGO–(BUSINESS WIRE)–Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) will report its financial results for the three months ended June 30, 2022 after the close of stock market hours on Thursday, August 4, 2022. Allscripts management plans to host a conference call and webcast to discuss the company’s earnings at 4:30 p.m. Eastern Time that same day. … [Read more…]

BOSTON–(BUSINESS WIRE)–Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its second quarter 2022 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 4, 2022. Individuals interested in participating in the call should dial (888) 330-2384 (U.S. and Canada) or (240) 789-2701 (international) using conference ID number and event … [Read more…]

Transaction to support potential commercialization of neffy™, ARS’s needle-free epinephrine nasal spray Well-funded with at least three years of operating runway expected Companies to host conference call today, July 21, 2022, at 5:00 p.m. ET SEATTLE & SAN DIEGO–(BUSINESS WIRE)–Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”) and ARS Pharmaceuticals, Inc. (“ARS”) today announced that the companies … [Read more…]

SAINT GEORGE, Utah–(BUSINESS WIRE)–Praesidium, Inc, a Saint George, Utah-based technology company that specializes in non-contact vital sign detection, announced today that they have finalized a commercial agreement with two other business partners to launch an innovative, next generation “intelligent sleep” mattress early next year. This announcement represents the culmination of nearly a year of research … [Read more…]

PORTLAND, Ore.–(BUSINESS WIRE)–Sklip Receives Breakthrough Designation from the FDA Sklip Inc. is excited to officially announce that it has received a Breakthrough Designation Device status by the US Food and Drug Administration (FDA). Sklip System AI is a tool that uses Artificial Intelligence technology to increase the early detection of skin cancers. The FDA’s Breakthrough … [Read more…]

Strengthening discussions with regulatory authorities to accelerate the clinical development of glenzocimab for its potential benefit in the treatment of stroke 87 patients already enrolled in Europe in the ACTISAVE Phase 2/3 registration study in stroke patients PARIS–(BUSINESS WIRE)–ACTICOR BIOTECH (Paris:ALACT) (ISIN: FR0014005OJ5 – ALACT), a clinical-stage biotechnology company developing innovative drugs for the treatment … [Read more…]

Where Early AI Deployments Have Failed to Produce Real-World Results, Bayesian Demonstrates Reduced Mortality, Long-Term Efficacy, High Adoption and Fewer False Alerts in a Trio of Prospective, Peer-Reviewed Studies NEW YORK–(BUSINESS WIRE)–Bayesian Health, the leading artificial intelligence (AI)-based Intelligent Care Augmentation platform developer, today announced release of three large, prospective multisite cohort studies, a first … [Read more…]